Table 2 Changes of FBG, FBI and MOMA-IR levels in rats of each group (mean ± SD)
From: Effects of rosuvastatin on serum glucose and insulin in hyperuricemic rats
Groups | FBG (mmol/L) | FBI (mmol/L) | HOMA-IR | ||||||
|---|---|---|---|---|---|---|---|---|---|
Week 0 | Week 2 | Week 4 | Week 0 | Week 2 | Week 4 | Wee 0 | Week 2 | Week 4 | |
Control | 6.05 ± 0.34 | 5.19 ± 1.01 | 5.36 ± 1.04 | 16.19 ± 5.61 | 18.97 ± 7.10 | 19.05 ± 8.21 | 4.35 ± .33 | 4.37 ± 0.57 | 4.54 ± 0.38 |
Model | 5.83 ± 0.73 | 12.05 ± 3.53 a | 15.05 ± 1.37 ac | 18.35 ± 4.34 | 17.69 ± 8.15 | 16.23 ± 9.08 | 4.75 ± 0.46 | 9.47 ± 0.39a | 11.01 ± 0.61 ac |
Rosuvastatin | 5.99 ± 0.56 | 17.05 ± 1.09 a | 22.05 ± 2.08 ab | 16.87 ± 9.26 | 20.14 ± 4.34 | 18.45 ± 8.12 | 4.49 ± 0.12 | 15.26 ± 0.16 ab | 18.08 ± 0.34 ab |